3-(4-FLUOROPHENYLAMINO)-3-OXOPROPANOIC ACID, 97.0%, 250mg

(2R,5R)-1-(2-[(2R,5R)-2,5-Diethyl-1-phospholanyl]phenyl)-2,5-diethylphospholane 1-oxide, 97%, 100mg

Kobalt(II)-acetat Tetrahydrat, min. 98 %, reinst, 500 g, kunststoffverpackung.

3-Bromo-1-methylpyrrolidin-2-one, 97.0%, 500mg

2,6-dimethyl-4-[(oxiran-2-yl)methyl]morpholine, 95.0%, 2g

6-Quinolinecarboxaldehyde>98.0%(GC)(T)5g

tert-Butyl ((3R,4R)-4-aminotetrahydro-2H-pyran-3-yl)carbamate, 95.0%, 1g

Ethyl pyrrolidine-3-carboxylate hydrochloride, 95.0%, 1g

2-Bromo-4-methylthiophene, 95.0%, 1g

Dichloro(mesitylene)ruthenium(II) dimer, 97.0%, 1g

(2S,2'S,3S,3'S)-3,3'-Di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole, 97%, 500mg

Reaktionsgefäß 6000 ml

Di-tert-butyl 4-chloropyridine-2,6-dicarboxylate, 95%, 1g